Haemodialysis Vascular Market Size by Raw Materials, End User, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2030
Overview
Haemodialysis Vascular Grafts Market is expected to grow at a CAGR of 4.1% during the forecast period. Global Haemodialysis Vascular Grafts Market is expected to reach US$ 339.25 Mn. by 2030.
Haemodialysis vascular access dysfunctioning is a major reason for illness in the patients having haemodialysis and it also contributes notably towards total end-phase renal disorder expenses. Arteriovenous (AV) grafts refer to the type of access used in the process of haemodialysis and is usually placed in the arm. The blood-flow through the graft helps in a providing a systematic flow pattern and controlled flow rate that helps to deliver enough blood for an adequate haemodialysis treatment.
To know about the Research Methodology :- Request Free Sample Report
According to WHO, the number of end stage renal disease patients globally, receiving dialysis will be approximately 5.24 Million by 2030. The cases associated with morbidity are mostly due to infection, haemorrhage and vascular grafts rejection by the human body. Due to the rejection reason of grafts by body, synthetic materials are being made with a blend of polymers to achieve the desired material strength, adhesion and durability. Bioengineered materials are expected to be the trendsetters in the forecast period, reason being the advantages such as negligible graft rejection and outstanding biocompatibility.
Moreover, the increasing smoking cases are an important factor for driving the market demand. Increasing demand for minimally invasive surgeries, rising vascular disorders and diabetes are also augmenting the market growth. In addition, the rising geriatric population, cardiac arrest cases, diabetes and hypertension due to changing lifestyle are also responsible for rise in market revenue.
Advancements in technology, funding for healthcare sector, increased activities in the R&D field also play a vital role. Emerging markets and increasing interest of stakeholders in investing here is expected to create new opportunities for haemodialysis vascular grafts market in the coming years.
The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Haemodialysis Vascular Grafts market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges.
The report has profiled ten key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.
Haemodialysis Vascular Grafts Market Segment Analysis
By Raw materials, the Polytetrafluoroethylene segment is expected to lead the market with a revenue share of xx% in the forecast period.
The Polytetrafluoroethylene segment held a prominent share of xx% in the year 2023 and is expected to continue the same. The reason being, it’s magnificent adhesion properties and fistula pliability. Characteristics such as high dielectric strength and low coefficient friction ensures smooth dialysis procedure in patients. Polyurethane holds second position in the market, owing to its material strength and a thinner inner wall as a vascular graft.
Due to this, a larger diameter gets provided and ensures proper blood flow during the haemodialysis procedure. The Biological material segment is expected to be the fastest growing during the forecast period. Less infection rate, negligible graft rejection and low haemorrhage chances are the factors responsible for the segment growth.
By end-use, the hospital segment is expected to register a CAGR of xx% during the forecast period. Hospitals held a leading revenue share of xx% in the Haemodialysis Vascular Grafts market in 2023. Surgeries and other operations are performed majorly in hospitals, due to availability of all tools and technologies required. Haemodialysis procedures conducted in hospitals or hospital-attached outpatient facilities enable ease of handling any emergency situations that may arise.
Haemodialysis Vascular Grafts Market Regional Insights
North America accounted for the largest share of Laparoscopic Ablation Devices Market in 2023
North America accounted for the largest share of xx% in 2023, reason being the rising prevalence of chronic kidney diseases. According to CDC, approximately 4.9 million people were diagnosed with kidney disease in US in 2017. Investments by key players in this field has boosted the market growth.
The rising number of haemodialysis procedures in North America and the technological advancements in dialysis devices introduced by key market players in this region are rising the market growth. The high class infrastructure with all surgery facilities available is also propelling the market growth in this region.
Asia Pacific is also expected to witness significant growth of xx% during the forecast period due to the increasing renal disorder cases. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected drive the market demand.
Haemodialysis Vascular Grafts Market Scope:Inquire before Buying
| Haemodialysis Vascular Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 256.07 Mn. |
| Forecast Period 2024 to 2030 CAGR: | 4.1% | Market Size in 2030: | US $ 339.25 Mn. |
| Segments Covered: | by Raw Materials | Polyester Polytetrafluoroethylene Polyurethane Biological Materials |
|
| by End User | Hospitals Ambulatory Care Centers Others |
||
Haemodialysis Vascular Grafts Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America
Haemodialysis Vascular Grafts Market, Key Players
1. W.L. Gore & Associates
2. C.R. Bard, Inc
3. Terumo Medical Corporation
4. LeMaitre Vascular, INC
5. Gentinge AB
6. Vascular Genesis
7. InnA Vasc Medical, INC
8. CryoLife, INC
9. Merit Medical Systems, INC
10. Proteon Therapeutics, INC
Frequently Asked Questions:
1] What segments are covered in Global Haemodialysis Vascular Grafts Market report?
Ans. The segments covered in Burn Ointment Market report are based on Product, Depth of Burn, and End-Use.
2] Which region is expected to hold the highest share in the Global Haemodialysis Vascular Grafts Market?
Ans. North America is expected to hold the highest share in the Burn Ointment Market.
3] Which segment holds the largest market share in the Global Haemodialysis Vascular Grafts Market by 2030?
Ans. Topical Antibiotics segment hold the largest market share in the Burn Ointment market by 2030.
4] What is the market size of the Global Haemodialysis Vascular Grafts Market by 2030?
Ans. The market size of the Burn Ointment market is expected to reach US $339.25 Mn. by 2030.
5] What was the market size of the Global Haemodialysis Vascular Grafts Market in 2023?
Ans. The market size of the Burn Ointment market was worth US $256.07 Mn. in 2023.